HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of erythropoietin-induced hemopoiesis on peritoneal transport and on in vitro T cell response in CAPD.

AbstractUNLABELLED:
In order to investigate the therapeutic efficacy of subcutaneously administered erythropoietin (rHuEPO) and the effects of rHuEPO-induced hemopoiesis on peritoneal transport and on cellular immune responses, we performed standardized peritoneal equilibration tests and measured T cell subsets and phytohemagglutinin (PHA)-induced interleukin-2 receptor (IL-2R) expression of PBMC by flow cytometry before and after subcutaneous rHuEPO (Eprex-, Cilag), 4000 U twice weekly, in 13 stable CAPD patients. Hct increased from 21.3 +/- 3.4% to 30.0 +/- 4.8% after 1 mo and to 32.7 +/- 4.9% after 2 mon of rHuEPO. Drained volume after 4 hrs of dwell with 4.25% dialysate increased from 2,675 +/- 204 ml to 2,807 +/- 174 ml (P < 0.05). D4/P4 creatinine increased from 0.68 +/- 0.07 to 0.71 +/- 0.06 (P < 0.05) and creatinine clearance from 7.57 +/- 0.71 to 8.03 +/- 0.63 ml/min (P < 0.05). The number of total circulating lymphocytes, T4,T8, T4/T8 with or without PHA did not change after rHuEPO. PHA-induced IL-2R expression by PBMC as expressed by mean channel of fluorescence intensity increased from 149.8 +/- 6.7 to 156.8 +/- 6.1 (P < 0.05).
CONCLUSION:
Subcutaneous rHuEPO is effective in correcting anemia in CAPD patients. rHuEPO-induced hemopoiesis is associated with increase in peritoneal creatinine and water transport and also with PHA-induced IL-2R expression.
AuthorsS K Lee, M S Park, D C Han, S D Hwang, C Moon, H B Lee
JournalAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis (Adv Perit Dial) Vol. 8 Pg. 453-6 ( 1992) ISSN: 1197-8554 [Print] Canada
PMID1361846 (Publication Type: Journal Article)
Chemical References
  • Hemoglobins
  • Phytohemagglutinins
  • Receptors, Interleukin-2
  • Recombinant Proteins
  • Erythropoietin
Topics
  • Adult
  • Anemia (etiology, therapy)
  • Biological Transport
  • Erythropoietin (therapeutic use)
  • Female
  • Hematocrit
  • Hematopoiesis
  • Hemoglobins (analysis)
  • Humans
  • In Vitro Techniques
  • Leukocyte Count
  • Male
  • Monocytes (metabolism)
  • Peritoneal Dialysis, Continuous Ambulatory
  • Peritoneum (metabolism)
  • Phytohemagglutinins
  • Receptors, Interleukin-2 (metabolism)
  • Recombinant Proteins (therapeutic use)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: